首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   498580篇
  免费   47460篇
  国内免费   197篇
  546237篇
  2018年   5474篇
  2017年   5359篇
  2016年   6713篇
  2015年   7215篇
  2014年   8840篇
  2013年   12425篇
  2012年   14759篇
  2011年   15298篇
  2010年   10166篇
  2009年   9365篇
  2008年   13375篇
  2007年   13884篇
  2006年   13410篇
  2005年   15701篇
  2004年   15499篇
  2003年   14130篇
  2002年   12269篇
  2001年   24780篇
  2000年   24825篇
  1999年   19093篇
  1998年   5681篇
  1997年   5856篇
  1996年   5414篇
  1995年   4931篇
  1994年   4870篇
  1993年   4884篇
  1992年   15031篇
  1991年   15105篇
  1990年   14630篇
  1989年   14422篇
  1988年   13427篇
  1987年   12560篇
  1986年   11414篇
  1985年   11452篇
  1984年   9060篇
  1983年   7730篇
  1982年   5383篇
  1981年   4713篇
  1980年   4564篇
  1979年   8299篇
  1978年   6408篇
  1977年   5834篇
  1976年   5408篇
  1975年   6310篇
  1974年   6763篇
  1973年   6634篇
  1972年   5928篇
  1971年   5539篇
  1970年   4825篇
  1969年   4686篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
D-2 dopamine receptors in the frontal cortex of rat and human   总被引:2,自引:0,他引:2  
D R Liskowsky  L T Potter 《Life sciences》1985,36(16):1551-1559
D-2 dopamine receptors and serotonin receptors in the frontal cortex of rat and human were labelled with 3H-spiroperidol. The D-2 receptors were then distinguished in 4 ways. Dissociation of spiroperidol was biphasic, indicating two populations of sites. Cinanserin in competition with 3H-spiroperidol exhibited high (75%) and low (25%) affinity sites. Dopamine and LY 141865 in competition with 1.25 nM 3H-spiroperidol exhibited high (20-25%) and low (80-75%) affinity sites in the absence of cinanserin, while in the presence of 300 nM cinanserin only the high affinity sites remained. Lesioning of the dopaminergic meso-cortical pathway increased the number of cinanserin-resistant sites by 26%. Thus 3H-spiroperidol binding in the presence of cinanserin can be used to selectively label D-2 receptors in the frontal cortex.  相似文献   
102.
103.
104.
The effects on a cloned DNA fragment carrying an actinomycin resistance determinant on physiological processes in strains of streptomycetes with various potencies in producing this antibiotic, their inactive mutants, and the model strain ofStreptomyces lividans66 were studied. This fragment was shown to modulate bacterial resistance to actinomycin and biosynthesis of antibiotics.  相似文献   
105.
The nucleotide sequences of a partial cDNA and three pseudogenes of human cytochrome c were determined. The complete nucleotide sequences which encode human cytochrome c were constructed on the basis of one of the pseudogenes by in vitro mutagenesis. The constructed human cytochrome c was functionally expressed in Saccharomyces cerevisiae. The recombinant human cytochrome c was purified and characterized.  相似文献   
106.
107.
Indirect evidence has suggested that the Msh2-Msh6 mispair-binding complex undergoes conformational changes upon binding of ATP and mispairs, resulting in the formation of Msh2-Msh6 sliding clamps and licensing the formation of Msh2-Msh6-Mlh1-Pms1 ternary complexes. Here, we have studied eight mutant Msh2-Msh6 complexes with defective responses to nucleotide binding and/or mispair binding and used them to study the conformational changes required for sliding clamp formation and ternary complex assembly. ATP binding to the Msh6 nucleotide-binding site results in a conformational change that allows binding of ATP to the Msh2 nucleotide-binding site, although ATP binding to the two nucleotide-binding sites appears to be uncoupled in some mutant complexes. The formation of Msh2-Msh6-Mlh1-Pms1 ternary complexes requires ATP binding to only the Msh6 nucleotide-binding site, whereas the formation of Msh2-Msh6 sliding clamps requires ATP binding to both the Msh2 and Msh6 nucleotide-binding sites. In addition, the properties of the different mutant complexes suggest that distinct conformational states mediated by communication between the Msh2 and Msh6 nucleotide-binding sites are required for the formation of ternary complexes and sliding clamps.  相似文献   
108.
109.
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号